Log in or Sign up for Free to view tailored content for your specialty!
Pharmacology News
VIDEO: Treating opioid use disorder in primary care
CHICAGO — Now more than ever, opioid use disorder must be treated by primary care physicians, according to Ann R. Garment, MD, FACP, a clinical associate professor at the NYU Grossman School of Medicine.
VIDEO: Managing obesity and factors that influence weight gain
CHICAGO — In this video, Adrienne Youdim, MD, FACP, discusses the social factors driving the rising prevalence of obesity in the United States.
Log in or Sign up for Free to view tailored content for your specialty!
‘There’s a real risk there’: Cannabis use exacerbates depression
CHICAGO — Cannabis has been approved by state legislators across the United States for more than 50 medical indications, according to a speaker at the ACP Internal Medicine Meeting.
Recent research that should influence practice
CHICAGO — Two speakers here reviewed what they believed were the top articles published in the Annals of Internal Medicine — research that reflects a diverse body of health issues and pharmacologic interventions.
VIDEO: Innovations in diabetes management
CHICAGO — In this video, Rajesh K. Garg, MD, the director of the Comprehensive Diabetes Center at the University of Miami Miller School of Medicine, discusses three evolving areas in diabetes management: glucose goals, treatment and devices.
Practical tips for deprescribing in older adults
CHICAGO — While there are several challenges to deprescribing, applying a practical algorithm of care may ease some of the anxiety that older patients experience during this process, according to a presentation at the ACP Internal Medicine Meeting.
VIDEO: Managing obesity with nutrition, pharmacotherapy and bariatric surgery
CHICAGO — In this video, Healio Primary Care Peer Perspective Board Member Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS, discusses her presentations on obesity from the ACP Internal Medicine Meeting.
FDA approves first treatment for young children with COVID-19
The FDA has approved Veklury for pediatric patients aged 28 days and older who are hospitalized for COVID-19 or have mild to moderate COVID-19 and are at risk for severe disease.
WHO recommends Paxlovid for patients with non-severe COVID-19
WHO has announced that it strongly recommends administering Pfizer’s Paxlovid to patients with non-severe COVID-19 who are at highest risk for hospitalization.
Adults with lower socioeconomic status more likely to use obesogenic medications
Adults with a lower socioeconomic status were more likely to use obesogenic medications, even after adjusting for comorbidity and medication burden, according to findings published in The Lancet Regional Health Americas.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read